Resumen acción VRAY.Q
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de ViewRay, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$4.96 |
| 52 Week Low | US$0.000001 |
| Beta | 0.76 |
| 1 Month Change | -98.88% |
| 3 Month Change | -99.57% |
| 1 Year Change | -100.00% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Noticias y actualizaciones recientes
Recent updates
Market Cool On ViewRay, Inc.'s (NASDAQ:VRAY) Revenues Pushing Shares 63% Lower
Apr 17
Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Dec 24ViewRay MRI-guided radiation therapy selected by SUNY upstate cancer center
Oct 06ViewRay's MRI-guided radiation therapy gets approval in China
Sep 07ViewRay MRI-guided radiation therapy selected by VA Houston Healthcare System
Aug 23ViewRay: Insider Buying In This $3 Stock
May 15Health Check: How Prudently Does ViewRay (NASDAQ:VRAY) Use Debt?
Apr 22Is ViewRay (NASDAQ:VRAY) Using Debt Sensibly?
Aug 09ViewRay, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 08Read This Before Selling ViewRay, Inc. (NASDAQ:VRAY) Shares
Mar 03How Many ViewRay, Inc. (NASDAQ:VRAY) Shares Do Institutions Own?
Jan 27
ViewRay rallies premarket on Q4 preliminary revenue
Jan 04ViewRay's (NASDAQ:VRAY) Stock Price Has Reduced 56% In The Past Three Years
Dec 22ViewRay +10.6% on CEO acquiring shares
Nov 12Rentabilidad de los accionistas
| VRAY.Q | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0% | -2.4% | -1.7% |
| 1Y | -100.0% | 3.6% | 22.9% |
Rentabilidad frente al sector: VRAY.Q obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del -1.8%.
Rentabilidad vs. Mercado: VRAY.Q obtuvo unos resultados inferiores a los del mercado US, que fue del 15.2% el año pasado.
Volatilidad de los precios
| VRAY.Q volatility | |
|---|---|
| VRAY.Q Average Weekly Movement | 2,748.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: VRAY.Qha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: VRAY.QLa volatilidad semanal ha pasado de 1401% a 2748% en el último año.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2004 | 295 | Paul Ziegler | www.viewray.com |
Resumen de fundamentos de ViewRay, Inc.
| Estadísticas fundamentales de VRAY.Q | |
|---|---|
| Capitalización bursátil | US$18.34k |
| Beneficios(TTM) | -US$110.41m |
| Ingresos (TTM) | US$105.86m |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está VRAY.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VRAY.Q | |
|---|---|
| Ingresos | US$105.86m |
| Coste de los ingresos | US$97.34m |
| Beneficio bruto | US$8.52m |
| Otros gastos | US$118.94m |
| Beneficios | -US$110.41m |
Últimos beneficios comunicados
Mar 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.60 |
| Margen bruto | 8.05% |
| Margen de beneficio neto | -104.30% |
| Ratio deuda/patrimonio | 140.7% |
¿Cómo se ha desempeñado VRAY.Q a largo plazo?
Ver rendimiento histórico y comparativa